NICE nod for new Eylea indication
admin 22nd September 2017 Uncategorised 0The National Institute for Health and Care Excellence (NICE) has issued a final positive recommendation for Bayer’s Eylea as a treatment for adults for the treatment of visual impairment due to myopic chorodial neovascularisation.
More: NICE nod for new Eylea indication
Source: News